(48) did not support the existence of this proximal-distal incretin loop in humans as intravenous injection of GIP into humans did not enhance GLP-1 secretion, pointing to the fact that the animal models may differ from humans in essential physiology
In preclinical work, BPC-157s neuro effects center on angiogenesis (via the VEGFR2AkteNOS pathway), nitric-oxide-system modulation, and neuroprotection, plus braingut neurotransmitter effects
Combined with liposomal form, it is one of the most advanced supplementation methods available today
Allergy 35 , 10961103 (2005)
However, it is essential to take these supplements at adequate doses
The future of GLP-1 dosing The dosing landscape is evolving rapidly